Dr. Lober is a board-certified neurosurgeon and director of the Living Biobank at Dayton Children's Hospital. Through Dayton Children’s affiliation with the Wright State University & Premier Health Neuroscience Institute, Dr. Lober is researching brain tumors in children, using advanced imaging and molecular techniques in search of a cure. This initiative is bridging the gap between pediatric neurosurgeons, pediatric oncologists, physicists, mathematicians, radiologists, pathologists, biochemists and many others within Dayton Children’s and the Neuroscience Institute.
Coming to Dayton Children’s from Lucile Packard Children’s Hospital in Palo Alto, California, Dr. Lober completed a fellowship in pediatric neurosurgery and pediatric neuro-oncology, a rare combination for a pediatric surgeon. He served his residency at Stanford Hospitals and Clinics in Stanford, California. He earned his medical degree and a PhD in Biomedical science at Georgia Regents University in Augusta, Georgia.
Dr. Lober is a member of the Scientific Committee for The Children's Brain Tumor Network, a collaborative, multi-institutional research program dedicated to the study and treatment of childhood brain tumors. CBTN includes some of the finest pediatric institutions in the world, and provides free and open access data to find a cure for pediatric brain cancer. Dayton Children's is one of 21 member institutions across five countries.
Dr. Lober is on the board of directors for the Children’s Brain Tumor Foundation (CBTF), a national organization dedicated to improving the treatment, quality of life, and long-term outlook for children and families affected by a brain or spinal cord tumor.
"It's a humbling thing when someone entrusts you with their child. It really feels like you are holding all of their hopes and dreams in your hands. I don't take that lightly at all."
Meet Dr. Lober
Learn more about Dr. Lober both inside and outside of work!
searching for a cure
Learn more about how Dr. Lober's research is helping to find treatment and cures for childhood brain tumors.